Mavandadi, S.

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology

Parkinson's Disease Mechanisms and TreatmentsTreatment of Major Depression

Cited by 255

Factors Associated With Long-term Benzodiazepine Use Among Older Adults

Gerlach, L. B., Maust, D. T., Leong, S. H., Mavandadi, S., & Oslin, D. W. (2018) · JAMA Internal Medicine

Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder Treatment

Cited by 43

Racial Disparities in Prescription of Antidepressants Among U.S. Veterans Referred to Behavioral Health Care

Remmert, J. E., Guzman, G., Mavandadi, S., & Oslin, D. (2022) · Psychiatric Services

Mental Health Treatment and AccessHealth disparities and outcomes

Cited by 13

Sleep disturbance predictors in OEF/OIF vets reporting trauma: (717652011-017)

Gellis, L. A., Gehrman, P. R., Mavandadi, S., & Oslin, D. W. (2010) · PsycEXTRA Dataset

Sleep and related disordersPosttraumatic Stress Disorder Research

Cited by 0